Daryl C. Drummond
2017
In 2017, Daryl C. Drummond earned a total compensation of $764.6K as Head of Research at Merrimack Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $99,393 |
|---|---|
| Option Awards | $390,240 |
| Salary | $263,376 |
| Other | $11,612 |
| Total | $764,621 |
Drummond received $390.2K in option awards, accounting for 51% of the total pay in 2017.
Drummond also received $99.4K in non-equity incentive plan, $263.4K in salary and $11.6K in other compensation.
Rankings
In 2017, Daryl C. Drummond's compensation ranked 10,214th out of 14,666 executives tracked by ExecPay. In other words, Drummond earned more than 30.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,214 out of 14,666 | 30th |
Division Manufacturing | 3,958 out of 5,772 | 31st |
Major group Chemicals And Allied Products | 1,391 out of 2,075 | 33rd |
Industry group Drugs | 1,129 out of 1,731 | 35th |
Industry Pharmaceutical Preparations | 883 out of 1,333 | 34th |
Source: SEC filing on April 27, 2018.
Drummond's colleagues
We found six more compensation records of executives who worked with Daryl C. Drummond at Merrimack Pharmaceuticals in 2017.
2017
Richard Peters
Merrimack Pharmaceuticals
Chief Executive Officer
2017
Jeffrey Munsie
Merrimack Pharmaceuticals
General Counsel
2017
Sergio Santillana
Merrimack Pharmaceuticals
Chief Medical Officer
2017
Jean Franchi
Merrimack Pharmaceuticals
Chief Financial Officer
2017
Yasir Al-Wakeel
Merrimack Pharmaceuticals
Chief Financial Officer
2017
Gary Crocker
Merrimack Pharmaceuticals